The discovery of cures for cancer are rare, but in the last 20 years, we have seen remarkable progress, highlighted by the discovery and development of immune checkpoint blockade therapies. Then, in 2022, the unimaginable happened. Dr. Andrea Cercek, a medical oncologist from Memorial Sloan Kettering Cancer Center, and colleagues reported that the use of immune checkpoint blockade cured 12 patients with a specific type of rectal cancer.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



